A First-in-Human SAD/MAD Study to Evaluate Safety, Tolerability and PK of ENC0653 Ointment in Healthy Adult Subjects

NCT07684196 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Low Dose, 10%BSA
DRUG: Low Dose, 20%BSA
DRUG: Middle Dose, 20%BSA
DRUG: High Dose, 20%BSA
DRUG: Low Dose, 20%BSA
DRUG: Middle Dose, 20%BSA
DRUG: High Dose, 20%BSA
DRUG: Placebo

Sponsor

EnnovaBio